Abstract:Background and purpose:Transcriptional silencing by promoter methylation is now believed to be an important mechanism of carcinogenesis. High frequency of promoter methylation of hMLH1, E-cadherin, and p16INK4a gene is detected in various tumours. This study was to detect the methylation pattern of hMLH1, E-cadherin and p16INK4a gene in esophageal squamous cell carcinoma and explore the role of these epigenetic changes in tumorigenesis. Methods:The frozen tumor specimens and matched normal mucosal tissue specimens from 105 patients with esophageal squamous carcinoma were used for the extraction of DNA by phenol-chloroform method. Methylation changes in the promoter region of hMLH1,E-cadherin, and p16INK4a genes were determined by using methylation-specific PCR (MSP). Immunohistochemical staining of hMLH1, E-cadherin, and p16INK4a protein was performed by using EnVision two-step method in the tumor tissues. Results:The positive rates of genes promoter hypermethylation of E-cadherin, hMLH1, and p16INK4a were 57.1% (60/105), 20.9% (22/105) and 50.5% (53/105) in tumor tissues, as compared to 10.5% (11/105), 1.9% (2/105) and 7.6% (8/105) in normal mucosal tissue, respectively. The positive rates were signifi cantly higher in tumor tissues than in normal mucosal tissue for each of the three genes. The absence rates of protein expression of E-cadherin, hMLH1, andp16INK4a were 48.6% (51/105), 21.9% (23/105) and 71.4% (75/105) respectively. Promoter hypermethylation of E-cadherin (P=0.021) or p16INK4a (P=0.026) gene was remarkably associated with the loss of protein. hMLH1 promoter hypermethylation was not signif icantly correlated with the loss of protein. ESCC with E-cadherin gene promoter hypermethylation was signifi cantly correlated with lymph node metastasis (P=0.016), p16INK4a gene promoter hypermethylation was found more in poorly-differentiated squamous cell carcinoma (P=0.024), hMLH1 promoter hypermethylation was not associated with any of the clinicopathological features. Conclusion:P16INK4a promoter hypermethylation was associated with loss of protein and poor differentiation, which might be involved in the tumorigenic process of ESCC. E-cadherin promoter hypermethylation was correlated with expression deletion and lymph node metastasis, which may play a significant role in pathogenesis of ESCC. hMLH1 promoter hypermethylation might not be involved in tumorigenesis of ESCC.

Expression of ECRG4, a Novel Esophageal Cancer-Related Gene, Downregulated by CpG Island Hypermethylation in Human Esophageal Squamous Cell Carcinoma

ECRG4 Acts As a Tumor Suppressor Gene Frequently Hypermethylated in Human Breast Cancer.

The tumor-promoting function of ECRG4 in papillary thyroid carcinoma and its related mechanism

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

Expression and Epigenetic Silencing of Ecrg4 Gene in Breast Cancer

Downregulated ECRG4 is Associated with Poor Prognosis in Renal Cell Cancer and is Regulated by Promoter DNA Methylation

Cpg Island Methylation Status Of Mirnas In Esophageal Squamous Cell Carcinoma

Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling

Secretoglobin-3A1 Gene Promoter Hypermethylation Relevant to Esophageal Squamous Cell Carcinoma

ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma

Promoter methylation and its significance of hMLH1, E-cadherin and p16INK4a gone in esophageal squamous cell carcinoma

The Hypermethylation of the CDKN2A and CHFR Promoter Region is a Key Regulatory Mechanism of CDKN2A and CHFR Expression in Esophageal Squamous Cell Carcinoma

Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma

Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells

Hypermethylation of the GATA gene family in esophageal cancer

Methylation of LAPTM4B Promoter Region Influences Its mRNA Expression in Esophageal Cancer

CpG Island Methylator Phenotype of Cell-Cycle Regulators Associated with TNM Stage and Poor Prognosis in Patients with Oesophageal Squamous Cell Carcinoma

Dcc Promoter Hypermethylation in Esophageal Squamous Cell Carcinoma

Hypermethylation Status of RASSF1A Gene Promoter Region in Esophageal Squamous Cell Carcinoma

Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer

LOC441178 Overexpression Inhibits the Proliferation and Migration of Esophageal Carcinoma Cells via Methylation of miR-182